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Background
Tuberculosis (TB) drug research and development has
witnessed resurgence in recent times primarily due to
the high mortality rates despite the availability of front
line drugs and a prominent BCG vaccine. Synergy of TB
with HIV is another factor which has warranted a search
for newer therapeutic interventions. Treatment of latent
TB infection is also the need of the hour. Iron acquisi-
tion is an important virulence mechanism of Mycobac-
terium tuberculosis (MTB). To scavenge iron, bacterial
species have developed high affinity, low molecular
weight iron chelators termed as siderophores. To coun-
teract the detrimental effect of microbial iron acquisi-
tion systems, the host secretes a 21kDa lipocalin protein
(Siderocalin) that binds with these iron laden sidero-
phores in an attempt to restrict the growth of MTB
within host macrophages.
Methods
In the current study, using molecular docking tools, we
assessed the interactions of host Siderocalin with Myco-
bactin, Parabactin and Cepabactin structurally non simi-
lar siderophores from three different bacterial species-
MTB, Paracoccus and Burkholderia cepacia. A compari-
son of molecular level interactions of Siderocalin with
these siderophores was performed.
Results
Siderocalin forms energetically favourable and stable
complexes with parabactin and cepabactin. However the
unfavourable positive binding energies for mycobactin- a
salicylate derived MTB siderophore indicated that side-
rocalin does not dock well with mycobactin.
Conclusion
Siderocalin probably fails to disrupt the role of mycobac-
tin in acquiring iron for mycobacteria thereby helping
the pathogen to survive leading to progression of disease.
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